|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 13881 |
FusionGeneSummary for FRK_BEND3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FRK_BEND3 | Fusion gene ID: 13881 | Hgene | Tgene | Gene symbol | FRK | BEND3 | Gene ID | 2444 | 57673 |
| Gene name | fyn related Src family tyrosine kinase | BEN domain containing 3 | |
| Synonyms | GTK|PTK5|RAK | KIAA1553 | |
| Cytomap | 6q22.1 | 6q21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | tyrosine-protein kinase FRKPTK5 protein tyrosine kinase 5fyn-related kinasenuclear tyrosine protein kinase RAKprotein-tyrosine kinase 5 | BEN domain-containing protein 3 | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | P42685 | Q5T5X7 | |
| Ensembl transtripts involved in fusion gene | ENST00000606080, ENST00000538210, | ENST00000369042, ENST00000429433, | |
| Fusion gene scores | * DoF score | 5 X 4 X 5=100 | 5 X 2 X 4=40 |
| # samples | 5 | 5 | |
| ** MAII score | log2(5/100*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/40*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: FRK [Title/Abstract] AND BEND3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FRK | GO:0000122 | negative regulation of transcription by RNA polymerase II | 12837246 |
| Tgene | BEND3 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 21914818 |
| Tgene | BEND3 | GO:0034773 | histone H4-K20 trimethylation | 26100909 |
| Tgene | BEND3 | GO:0036124 | histone H3-K9 trimethylation | 26100909 |
| Tgene | BEND3 | GO:0043967 | histone H4 acetylation | 26100909 |
| Tgene | BEND3 | GO:0051260 | protein homooligomerization | 28977671 |
| Tgene | BEND3 | GO:0098532 | histone H3-K27 trimethylation | 26100909 |
| Tgene | BEND3 | GO:1903580 | positive regulation of ATP metabolic process | 28977671 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | CHOL | TCGA-ZH-A8Y1-01A | FRK | chr6 | 116381131 | - | BEND3 | chr6 | 107420500 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000606080 | ENST00000369042 | FRK | chr6 | 116381131 | - | BEND3 | chr6 | 107420500 | - |
| 5CDS-5UTR | ENST00000606080 | ENST00000429433 | FRK | chr6 | 116381131 | - | BEND3 | chr6 | 107420500 | - |
| intron-5UTR | ENST00000538210 | ENST00000369042 | FRK | chr6 | 116381131 | - | BEND3 | chr6 | 107420500 | - |
| intron-5UTR | ENST00000538210 | ENST00000429433 | FRK | chr6 | 116381131 | - | BEND3 | chr6 | 107420500 | - |
Top |
FusionProtFeatures for FRK_BEND3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FRK | BEND3 |
| Non-receptor tyrosine-protein kinase that negativelyregulates cell proliferation. Positively regulates PTEN proteinstability through phosphorylation of PTEN on 'Tyr-336', which inturn prevents its ubiquitination and degradation, possibly byreducing its binding to NEDD4. May function as a tumor suppressor.{ECO:0000269|PubMed:19345329}. | Transcriptional repressor which associates with the NoRC(nucleolar remodeling complex) complex and plays a key role inrepressing rDNA transcription. The sumoylated form modulates thestability of the NoRC complex component BAZ2A/TIP5 by controllingits USP21-mediated deubiquitination (PubMed:21914818,PubMed:26100909). Binds to unmethylated major satellite DNA and isinvolved in the recruitment of the Polycomb repressive complex 2(PRC2) to major satellites (By similarity). Stimulates the ERCC6Ltranslocase and ATPase activities (PubMed:28977671).{ECO:0000250|UniProtKB:Q6PAL0, ECO:0000269|PubMed:21914818,ECO:0000269|PubMed:26100909, ECO:0000269|PubMed:28977671}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FRK_BEND3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FRK_BEND3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| FRK | RB1, PTEN, KHDRBS1, FYN, HSP90AA1, CSK, BNIP2, SF3B4, EGFR, PCBP1 | BEND3 | USP21, SMARCAD1, SIRT7, BARD1, TP53BP1, HDAC1, RIOK2, BEND3, FAM161A, MORN4, NTRK1, CFAP97, NFATC1, BAZ2A, SMARCA5, FOXP3, NFATC2, ZNF785, MAP7D2 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FRK_BEND3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | FRK | P42685 | DB08896 | Regorafenib | Tyrosine-protein kinase FRK | small molecule | approved |
| Hgene | FRK | P42685 | DB01254 | Dasatinib | Tyrosine-protein kinase FRK | small molecule | approved|investigational |
Top |
RelatedDiseases for FRK_BEND3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | FRK | C0271650 | Impaired glucose tolerance | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|